• loading
  • +44 (0)20 8762 8008
  • Change Language
    [Close]
      • Language English
      • Language Japanese
      LanguageEnglish
  • Home
  • Overview
    • Pandemic
    • Bird Flu
  • Subscribers
    • Overview
    • References
    • Planning Tools
    • Travel Advice
    • Email Sign up
  • Locations
  • Newsroom
    • News
    • Editorials
    • FAQs

Quick Links

  • Home
  • About Us
  • Careers
  • CSR
  • Foundation
International SOS Logo
View Map
  • +44 (0)20 8762 8008 Call for Assistance
    • Language English
    • Language Japanese
    LanguageEnglish
  • Search
  • loading
    Log In
  • Home
  • Overview
    • Pandemic
    • Bird Flu
  • Subscribers
    • References
    • Planning Tools
    • Travel Advice
    • Email Sign up
  • Locations
  • Newsroom
    • News
    • Editorials
    • FAQs
  • About Us
  • Careers
  • CSR
  • Foundation
  • Pandemic Preparedness
  • 2019-nCoV
Print

COVID-19

 


Public Access

Interactive COVID-19 Data by Location

COVID-19 Case Count Trackers

Education and Communication

COVID-19 FAQs and External Resources

COVID-19 Videos

 

 

 

Member Access

 

Travel Restrictions, Flight Operations and Screening

Digital Passports

COVID-19 Digital Passports


Scientific Update

COVID-19 FAQs

COVID-19 Vaccine

COVID19 Vaccine FAQs

COVID-19 Vaccine FAQs

Variant

COVID-19 Variants

COVID-19 Testing

COVID-19 Treatment

Use of Face Masks by the General Public

COVID-19 Travel Advice


 

COVID-19 Disease and Prevention Article


Sign up for Emails and Alerts

 

Premium Services Member Access

 

 

 

COVID-19 Manager Advice


 

COVID-19 Case Definitions used by different authorities

Impact Tool

Pandemic Local Impact Tool

COVID-19 Communication Material


 

COVID modelling with R0 equations

COVID-19 Modelling

COVID-19 Useful Links


 

HOT TOPICS (PREMIUM ACCESS)

  1. …
  2. 14
  3. 15
  4. 16
  5. 17
  6. 18
  7. …
  • Interactive ventilation tool

    United States // 11 May, 2022

    Shows particle reduction with adjusting ventilation ...

    COVID-19, General Articles, Air Pollution

  • Study: Encephalopathy commonly noted in severe SAR-CoV-2 infection

    09 May, 2022

    At least one in ten patients with severe SAR-CoV-2 infection suffered encephalopathy...

    COVID-19

  • FDA limits use of J&J vaccine

    United States // 06 May, 2022

    Due to the risk of "thrombosis with thrombocytopenia syndrome (TTS)"...

    COVID-19

  • Similar viral load in vaccinated and unvaccinated people

    05 May, 2022

    Regardless of vaccination status, findings show viral load is similar...

    COVID-19

  • Vaccine update – Primary and booster vaccination age groups extended, second booster for some

    Taiwan (China) // 04 May, 2022

    The Taiwan Central Epidemic Command Centre announced that booster shots will be available five months after the second dose...

    COVID-19

  • CDC recommends use of masks during travel

    United States // 04 May, 2022

    Masks still recommended....

    COVID-19

  • COVID-19 Bivalent vaccines

    02 May, 2022

    Bivalent COVID-19 vaccines are second generation vaccines aimed at...

    COVID-19

  • Close to 60% of people have antibodies from previous COVID-19 infection

    United States // 29 April, 2022

    The highest rates were found among children...

    COVID-19

  • ECDC recommends 4th dose of COVID-19 vaccination for older age groups

    29 April, 2022

    Those over 80 and immunocompromised recommended a second booster...

    COVID-19

  • Remdesivir approved by FDA for treatment of COVID-19 in children

    United States // 26 April, 2022

    First treatment approved for children under 12...

    COVID-19

  • COVID-19 Update - rise in transmission in Honiara

    Solomon Islands // 22 April, 2022

    Mandatory self-isolation for cases and close contacts....

    COVID-19

  • WHO Q&A on COVID-19 therapeutics

    22 April, 2022

    WHO EURO published a Q&A on COVID-19 therapeutics...

    COVID-19

  • WHO updates recommended COVID-19 treatments

    21 April, 2022

    Updated recommendations for adults at high risk of hospitalisation...

    COVID-19

  • First cases of XE subvariant detected

    South Korea // 21 April, 2022

    Other subvariants also found…

    COVID-19

  • First case of COVID-19 XE recombinant variant

    Brazil // 20 April, 2022

    First XE case in the country...

    COVID-19

  • Initiative to reduce COVID-19 hospital admissions

    Rwanda // 19 April, 2022

    COVID-19 booster doses can be taken at three months after ..

    COVID-19

  • Booster dose of Pfizer/BioNTech in children shows good response

    United States // 16 April, 2022

    Clinical trial data showed good immune response after booster dose in children ages 5 to 11....

    COVID-19

  • Valneva COVID-19 vaccine approved

    United Kingdom // 15 April, 2022

    The Medicines and Healthcare products Regulatory Agency (MHRA) has approved the Valneva vaccine for...

    COVID-19

  • Vaccine Update - Vaccinations for children and issuance of vaccine passport begins

    Vietnam // 15 April, 2022

    Health authorities begin vaccinating children aged five to 11 years...

    COVID-19

  • COVID-19 breath test authorised

    United States // 15 April, 2022

    The United States Food and Drug Administration (FDA) issued an emergency use authorisation (EUA) for a COVID-19 diagnostic test that uses breath...

    COVID-19

  1. …
  2. 14
  3. 15
  4. 16
  5. 17
  6. 18
  7. …
  • Pandemic Home
  • Privacy
  • Contact Us
  • Feedback
  • Terms and Conditions
Footer Image


GeoNames logo

Additional data provided by

© 2024 International SOS